Therapeutic strategies targeting connexins

Nat Rev Drug Discov. 2018 Dec;17(12):905-921. doi: 10.1038/nrd.2018.138. Epub 2018 Oct 12.

Abstract

The connexin family of channel-forming proteins is present in every tissue type in the human anatomy. Connexins are best known for forming clustered intercellular channels, structurally known as gap junctions, where they serve to exchange members of the metabolome between adjacent cells. In their single-membrane hemichannel form, connexins can act as conduits for the passage of small molecules in autocrine and paracrine signalling. Here, we review the roles of connexins in health and disease, focusing on the potential of connexins as therapeutic targets in acquired and inherited diseases as well as wound repair, while highlighting the associated clinical challenges.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Communication / drug effects
  • Connexins / metabolism*
  • Gap Junctions / drug effects
  • Gap Junctions / metabolism
  • Humans
  • Signal Transduction / drug effects
  • Small Molecule Libraries / pharmacology*
  • Small Molecule Libraries / therapeutic use*
  • Wound Healing / drug effects

Substances

  • Connexins
  • Small Molecule Libraries